Australia's largest stock trading and investment forum Australia's #1 stock forum

CYP

Click for more information

3.85%

25.0¢ cynata therapeutics limited

This is a phase 1 trial.All the P2 'successes' that were...

First 14 Last

Share
Profile

Follow
Pledge

6,933 Posts.

1284

13/04/24

10:10

Post #: 73327059
Share

Originally posted by bedger: ↑

You are correct. CEO hinted at it. Was of course mocked by the usual detractors who are not paying enough attention to changes going on the FDA. DFU is of course a pressing issue in the US with far too many amputations for a first world country:

"Diabetes is the leading risk factor for lower-extremity amputation in U.S. adults, with an estimated 150,000 diabetes-related major or minor amputations per year. Lifetime risk of any lower-extremity amputation among people with DFU is at least 19%"

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797649/#:~:text=Diabetes%20is%20the%20leading%20risk,least%2019%25%20(56).

150,000!!! That's massive. Nearly 1 in 2,000 US people get amputations a year from Diabetes in the US, which is obviously rife. I think an accelerated approval on a phase II trial with a possible phase III confirmatory trial as a condition, a very real possibility.

Expand

This is a phase 1 trial.

All the P2 'successes' that were commercialised without a P3 were pulled from the market years later.

The last 'event' like that was 2018.

The CEO (KK) and you are deluded if you think the GVHD trial will commercialise on the P2 alone.

Anyway. Back to reality. This is a phase 1 trial. Try and pay attention.

CYP Price at posting: 18.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

There are more pages in this discussion • 20 more messages in this thread...

First 14 Last

Add CYP (ASX) to my watchlist

(20min delay)
Last 25.0¢		Change -0.010(3.85%)		Mkt cap ! $44.90M

Open	High	Low	Value	Volume
26.0¢	26.5¢	25.0¢	$5.869K	22.42K

Buyers (Bids)

No.	Vol.	Price($)
1	29342	25.0¢

Sellers (Offers)

Price($)	Vol.	No.
27.0¢	30000	1

View Market Depth

No.	Vol.	Price($)
1	29342	0.250
2	31297	0.245
4	107225	0.240
1	100000	0.235
2	15173	0.230

Price($)	Vol.	No.
0.270	30000	1
0.290	7125	3
0.295	183892	1
0.300	85000	2
0.310	16591	3

Last trade - 15.47pm 11/07/2024 (20 minute delay)

CYP (ASX) Chart